{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-106571","form_type":"8-K","ticker":"KODK","cik":"0000031235","company_name":"EASTMAN KODAK CO","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.023744+00:00","generated_at":"2026-05-17T15:51:34.738906+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Kodak Q2 net loss $26M; going concern doubt raised on debt obligations","bullets":["GAAP net loss of $26M vs net income of $26M in Q2 2024; revenue $263M, down 1% YoY.","Operational EBITDA $9M, down 25% YoY; lower volumes and higher aluminum and manufacturing costs.","Substantial doubt about going concern due to debt and preferred stock; pension reversion plan not solely within control.","AM&C pharma facility FDA-registered; will start PBS production, bridge to injectable IV saline.","Cash $155M, down $46M from Dec 31, 2024; Q2 cash use improved to $3M reduction."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-106571","json":"https://secwatch.observer/filing/0000950170-25-106571.json","markdown":"https://secwatch.observer/filing/0000950170-25-106571.md","text":"https://secwatch.observer/filing/0000950170-25-106571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31235/000095017025106571/0000950170-25-106571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31235/000095017025106571/kodk-20250811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:51:34.738906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}